Cyp3a4 22-related Pharmacokinetics Considerations
📧 Sign up to get email alerts when something new happens for Cyp3a4 22-related Pharmacokinetics Considerations.
Sign up free-
CLINICAL_TRIALS withdrawal · 2024-02-02Clinical Trial Update: Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype [Phase 4]
Phase IV multi-arm pharmacokinetics trial investigating CDK4/6 in healthy volunteers with CYP3A4*22 genotype has been withdrawn.